Webinars

Here are the past webinars of the REPROCELL Webinars series. Future webinars will be advertized on our upcoming events calendar.

See also our Learning Resources: Videos.

You can stay up to date with the latest REPROCELL video content on the REPROCELL YouTube Channel.

Webinar_series_cartoon_2

Webinar: HypoImmune iPS Cell Engineering and Genome Modification

Dr Yongming Luke Ren
Stem Cell Scientist, REPROCELL, Beltsville, MD

Webinar: Innovative Cell Technologies to Bioengineer Human Tissues In Vitro for Use in R&D and Modelling Human Disease
Prof. Stefan Przyborski
CSO, REPROCELL Europe & Professor in Cell Technology, Durham University, UK
Webinar: Raising the Standard: High-Quality and Reproducible Growth Factors for Advanced Cell Systems

Dr. Luana Ferrar
Qkine

Webinar: A Breath of Innovation: Immortalizing Alveolar Cells for Infection and Tox Testing
Dr. Tobias May
CSO, inscreenex GmbH, Germany
Webinar: Modeling cardiac pathologies with TrueCardium™: Engineered human tissue for drug discovery and cardiotoxicity screening

Prof. Jaya Krishnan

Webinar: Reproducible differentiation of pure ovarian support cells from clinical-grade hiPSCs as a novel infertility treatment
Dr Bruna Paulsen, PhD
VP of Manufacturing and Therapeutic Development, Gameto
Webinar: Biology Controlled: High Quality iPSC-Derived Human cells for Drug Discovery Therapy
Jan Jensen, PhD
CEO/CSO of Trailhead Biosystems
WEBINAR: Innovative Technology to Bioengineer Human Tissue
Prof. Stefan Przyborski
CSO, REPROCELL Europe & Professor in Cell Technology, Durham University, UK
Webinar: Bringing Mesenchymal Stromal Cells into the Clinic
Katia Lefsihane
Cellcolabs
Webinar: Mature Chamber Specific Human Cardiomyocytes for High Throughput Cardiotoxicity Testing
Anne E. Sheldrake, M.S.
StemBioSys
Todd J. Herron, Ph.D.
Frankel Cardiovascular Center, University of Michigan
Webinar: Production of Mesenchymal Stem Cells (MSCs) for Clinical and Research Projects
Evelyn Chukwurah, Ph.D.
REPROCELL USA
Naiarah de Paz, M.Sc.
COO, Histocell
Webinar: Things to consider when searching for a supplier of cGMP iPSCs
Dr Mahendra Rao
Webinar: Customized Central Laboratory Services for Support of Global Clinical Trials: PBMC Processing
Dr Nikola Kolundzic
Study Director, REPROCELL Europe, UK
Webinar: Working with Mature, Chamber-Specific Cardiomyocytes
Dr Travis Block
Chief Technology Officer, StemBioSys
Webinar: Human Tissue in Drug Discovery Scientific, Technical & Regulatory Perspective
David Bunton
CEO REPROCELL Europe
(founder of Biopta Ltd. now part of REPROCELL)
Webinar: Clinically compatible advances in blood-derived EPC isolation and reprogramming
Dr Amer Rana
Director of Biomedical Research Center, University of East Anglia, UK
Webinar: Enabling translational research through access to high quality biospecimens
Dr. Rachna Goyal
Manager, Preclinical Genomics, REPROCELL USA
Webinar: How to culture iPSCs in suspension without agitation
Masashi Iwakami
Nissan Chemical Corporation, Japan
Webinar: What is human tissue testing?
Dr David Bunton
CEO REPROCELL Europe
(founder of Biopta Ltd. now part of REPROCELL)
Webinar: Improving Precision Medicine With Human Tissue Testing and Genomics
Dr David Bunton
CEO REPROCELL Europe
(founder of Biopta Ltd. now part of REPROCELL)
Webinar: Bioengineered Human Tissues for Skin, Cancer, and Drug Metabolism
Prof. Stefan Przyborski
CSO, REPROCELL Europe & Professor in Cell Technology, Durham University, UK
Dr. James Shoemaker
CSO, Lena Biosciences, USA
Webinar: Review of Current Regulatory Issues on Ancillary Materials and Importance of Animal Origin Free Products
Dr. Takuya Matsumoto
Institute for BioScience at Ajinomoto Co. Inc. Japan
Webinar: Providing testing solutions for the development of SARS-CoV-2 therapeutics
Prof. Anne Dickinson
Translational and Clinical Research Institute, Faculty of Medical Sciences, University of Newcastle upon Tyne, UK
Dr. Terri Lehman
Chief Technical Officer, REPROCELL Bioserve, USA
Webinar: How Pharma is using fresh human tissues to better predict drug safety and efficacy
Dr David Bunton
CEO REPROCELL Europe
(founder of Biopta Ltd. now part of REPROCELL)
Webinar: Consistent and efficient hPSC culture with a novel animal-origin free culture system
Dr. Hajime Onuki
Ajinomoto Co. Inc.
Webinar: Providing safety testing solutions for the pharmaceutical and cosmetic industry
Dr. Shaheda Ahmed
Scientific Manager, Alcyomics Ltd. UK
Webinar: Using neural network activity readouts in human iPSC-derived neuron/glia co-cultures for in vitro neurotoxicity assessment
Dr. Daniel Haag
Head of Neuroscience and Co-founder of NeuCyte Inc. USA
Webinar: The development and application of advanced cell culture techniques to construct models of human tissues
Prof. Stefan Przyborski
CSO, REPROCELL Europe & Professor in Cell Technology, Durham University, UK
Webinar: Novel Uses for PCR of iPSCs in Drug Discovery and Cell Biology
Dr. Tsukasa Sugo
CEO and Founder of GenAhead Bio in Fujisawa, Japan
Webinar: The REPROCELL Biobank: A Unique Tool for Neurodegenerative Disease Research
Dr. Jean Phillipe Richard
Stem Cell Director, REPROCELL USA
Webinar: The REPROCELL Tissue Network: Facilitating Dermatological Drug Development
Dr. Karen McAuley
Clinical Alliances Manager, REPROCELL Europe
Graeme Macluskie
Director of Precision Medicine, REPROCELL Europe

On the REPROCELL blog

Latest

More on the blog

The Resurgence of New Approach Methodologies (NAMs) in Drug Discovery and Safety Assessment

The Resurgence of New Approach Methodologies (NAMs) in Drug Discovery and Safety Assessment

Explore how New Approach Methodologies are revolutionizing drug discovery and safety assessment by enhancing human-relevant research and reducing reliance on animal testing.

30 April 2026

Inside the Sample Lifecycle: How Central Labs Protect Data from Collection to Analysis

Inside the Sample Lifecycle: How Central Labs Protect Data from Collection to Analysis

Explore how central laboratories safeguard data integrity throughout the sample lifecycle, from collection to analysis, ensuring reliable outcomes in research.

13 April 2026

Mapping the Competitive Landscape of Human Tissue-Based Drug Discovery

Mapping the Competitive Landscape of Human Tissue-Based Drug Discovery

Explore how REPROCELL leads in human tissue-based drug discovery, addressing market gaps and offering innovative, disease-relevant solutions for better therapeutic outcomes.

02 April 2026

5 Hard Truths About Bringing Stem Cell Therapies to the Clinic

5 Hard Truths About Bringing Stem Cell Therapies to the Clinic

Discover the essential truths behind developing clinical-grade stem cell therapies and learn how to navigate the complexities of GMP manufacturing successfully.

30 March 2026